Comprehensive tumour-immune profiling reveals TREM2(+) tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma.

BACKGROUND: Lymph node (LN) metastasis is a well-established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation of suppressive tumour immune microenvironment (TIME) is a major contributor to tumour immune evasion and metastasis. However, the TIME landscape underlying LN-metastatic HNSCC remains poorly elucidated. METHODS: A total of 688 866 single-cell transcriptomes across 212 HNSCC samples were integrated. Comprehensive bioinformatic analyses on single-cell RNA sequencing and microarray datasets revealed a TREM2(+) tumour-associated macrophage (TAM) cluster associated with LN metastasis. The functional role of TREM2(+) TAMs was investigated through multiplex immunohistochemistry (mIHC) staining in clinical HNSCC cohort and in vitro co-culture experiments. Furthermore, machine learning algorithms were employed to construct a prognostic model for HNSCC. RESULTS: Integrative single-cell analysis revealed the immunosuppressive TIME of LN-metastatic HNSCC, characterised by high infiltration of exhausted CD8(+) T cells (CD8(+) Tex). We identified a specific TREM2(+) TAM cluster that was strongly associated with CD8(+) Tex infiltration and LN metastasis. In vitro experiment confirmed that TREM2(+) TAMs promoted CD8(+) T cell exhaustion. Mechanistically, TREM2(+) TAMs exhibited a terminally differentiated phenotype driven by ETV5, and secreted SPP1 to interact with CD44 on CD8(+) T cells, thus upregulating BHLHE40 to promote CD8(+) Tex formation. Clinically, a prognostic model based on TREM2(+) TAM signature genes was trained to independently predict HNSCC outcomes. CONCLUSIONS: This study delineates the mechanism that TREM2(+) TAMs promote LN metastasis in HNSCC by facilitating CD8(+) T cells exhaustion via SPP1-CD44-BHLHE40 axis, proposing TREM2(+) TAMs as potential therapeutic target for HNSCC.